Department of Life Sciences, University of Bath, Bath, UK.
Department of Social & Policy Sciences, University of Bath, Bath, UK.
BMJ Open. 2023 Oct 16;13(10):e075069. doi: 10.1136/bmjopen-2023-075069.
To explore the views of professional stakeholders on the future of community pharmacy services in England. Specific objectives related to expectations of how community pharmacy services will be provided by 2030 and factors that will influence this.
Qualitative, using semistructured interviews in person or via telephone/Skype. The topic guide was informed by a recent policy review that used the Walt and Gilson policy framework. Transcripts were analysed using inductive thematic analysis.
England.
External stakeholders were representatives of non-pharmacy organisations, including policy-makers, commissioners and representatives of healthcare professions. Internal stakeholders were community pharmacists or pharmacy organisation representatives. Interviewees were identified using stakeholder mapping RESULTS: In total, 25 interviews were completed (7 external stakeholders and 18 internal stakeholders, of which 10 were community pharmacists). Community pharmacy was recognised as having a key role in expanding health system capacity (''), particularly for long-term condition management (eg, adherence, reducing polypharmacy, monitoring), urgent care (eg, minor illnesses) and public health (including mental health). For these contributions to be developed and optimised, greater integration and collaboration with general practices will be needed (''), as well as use of technology in a patient-centred way and full access to health records. These changes will require workforce development together with appropriate commissioning and contractual arrangements. Community pharmacy is currently undervalued ('') and recent investment in general practice pharmacists rather than community pharmacy was seen as a missed opportunity.
Community pharmacy as a sector could and should be developed to increase health service capacity to address its current challenges. Numerous modifications are required from a range of stakeholders to create the environment in which these changes can occur.
探索专业利益相关者对英格兰社区药房服务未来的看法。具体目标涉及到对 2030 年社区药房服务将如何提供的期望,以及影响这一点的因素。
定性,采用面对面或通过电话/ Skype 进行半结构化访谈。主题指南是根据最近的一项政策审查制定的,该审查使用了 Walt 和 Gilson 政策框架。使用归纳主题分析对转录本进行分析。
英格兰。
外部利益相关者是指非药房组织的代表,包括政策制定者、专员和医疗保健专业人员的代表。内部利益相关者是社区药剂师或药房组织的代表。通过利益相关者绘图确定受访者。
共完成了 25 次访谈(7 名外部利益相关者和 18 名内部利益相关者,其中 10 名是社区药剂师)。社区药房被认为在扩大卫生系统能力方面发挥着关键作用(“”),特别是在长期疾病管理(例如,依从性、减少多药治疗、监测)、紧急护理(例如,小病)和公共卫生(包括心理健康)方面。为了发展和优化这些贡献,需要与全科医生更紧密地整合和协作(“”),以及以患者为中心的方式使用技术和全面访问健康记录。这些变化需要劳动力发展以及适当的委托和合同安排。社区药房目前被低估(“”),最近对全科医生药剂师的投资而不是对社区药房的投资被视为错失的机会。
社区药房作为一个行业,可以而且应该发展壮大,以增加卫生服务能力,应对当前的挑战。需要来自一系列利益相关者的众多修改,以创造可以实现这些变革的环境。